---
title: "LifeTech expects H1 net loss attributable to owners of RMB 30 million-RMB 40 million vs year-ago profit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295683843.md"
description: "LifeTech Scientific expects a net loss attributable to owners of RMB 30-40 million for H1 2026, swinging from a year-ago profit. This decline is driven by lower revenue, weaker exchange gains, and transaction expenses related to a scrapped Starway Medical acquisition. Excluding non-recurring items, net profit is projected at RMB 110-120 million, down significantly from RMB 238.5 million previously. Interim results are expected by the end of August 2026."
datetime: "2026-08-12T15:14:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295683843.md)
  - [en](https://longbridge.com/en/news/295683843.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295683843.md)
generator: "portal-rs"
---

# LifeTech expects H1 net loss attributable to owners of RMB 30 million-RMB 40 million vs year-ago profit

-   LifeTech flagged a sharp earnings drop for the six months ended June 30, 2026, based on unaudited management accounts. \* Net profit attributable to owners, excluding non-recurring items, seen at RMB 110-120 million, down from RMB 238.5 million a year earlier. \* Including non-recurring items, net result expected to swing to a loss of RMB 30-40 million from a profit of RMB 55.1 million. \* Decline driven by lower revenue, weaker net exchange gains, transaction expenses tied to a scrapped Starway Medical equity acquisition. \* Interim results for the period are expected by end-August 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeTech Scientific Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260812-12281935), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01302.HK](https://longbridge.com/en/quote/01302.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [LifeTech Scientific Flags Interim Loss on Lower Revenue and One-Off Costs](https://longbridge.com/en/news/295677243.md)
- [REG - American Century Inv Spire Healthcare Grp - Form 8.3 - Spire Healthcare Group PLC](https://longbridge.com/en/news/298045178.md)
- [Worldwide Healthcare Trust estimates Sept. 1 NAV at 414.74p per share (cum income)](https://longbridge.com/en/news/297798173.md)
- [Finepart wins USD 545,000 Finecut system order from US medtech customer](https://longbridge.com/en/news/298054599.md)
- [Worldwide Healthcare Trust estimates NAV per share at 419.04p as of Sept. 2 close](https://longbridge.com/en/news/297928949.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**